Corvus Pharmaceuticals, Inc. (CRVS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 608.03M |
| Enterprise Value | 604.39M |
| P/E Ratio | -22.84 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.7 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -24.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.17 |
| Return On Equity | -0.39 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -105,000 |
| EBITDA | -15.18M |
| Net Income | -15.28M |
| Diluted EPS | -0.53 |
| Total Cash | 236.71M |
| Total Cash/Share | 2.63 |
| Total Debt | 834,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 19.81 |
| Book Value Per Share | 2.67 |
| 52-Week Change | 236.73 |
| 52-Week High | 26.95 |
| 52-Week Low | 3.71 |
| Moving Average 50 Days | 13.8 |
| Moving Average 200 Days | 11.88 |
| Average Volume | 1.44M |
| Shares Outstanding | 84.09M |
| % Held by Institutions | 88.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |